CorMedix
CRMD
#7072
Rank
A$0.90 B
Marketcap
A$11.55
Share price
1.39%
Change (1 day)
-31.05%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2026 (TTM): A$0.27 Billion

According to CorMedix's latest financial reports the company's current earnings are A$0.40 Billion. In 2025 the company made an earning of A$0.21 Billion, an increase over its 2024 earnings that were of -A$27.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.27 B27.87%
2025 A$0.21 B-876.29%
2024 -A$27.72 Million-58.3%
2023 -A$66.47 Million53%
2022 -A$43.45 Million2.81%
2021 -A$42.26 Million8.32%
2020 -A$39.02 Million26.53%
2019 -A$30.84 Million-19.89%
2018 -A$38.49 Million-18.72%
2017 -A$47.35 Million34.56%
2016 -A$35.19 Million34.88%
2015 -A$26.09 Million-11.08%
2014 -A$29.34 Million124.69%
2013 -A$13.06 Million144.91%
2012 -A$5.34 Million-48.41%
2011 -A$10.34 Million-33.29%
2010 -A$15.5 Million78.42%
2009 -A$8.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
A$2.35 B 789.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$19.26 M-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$84.77 M-68.06%๐Ÿ‡บ๐Ÿ‡ธ USA